Correction.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 774, doi. 10.1002/cpdd.854
- Publication type:
- Article
Works matching IS 2160763X AND DT 2020 AND VI 9 AND IP 6
Results: 13
1
2
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Dupilumab in Healthy Adult Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 742, doi. 10.1002/cpdd.798
- By:
- Publication type:
- Article
3
Randomized, Double‐Blind, Single‐Dose, Placebo‐Controlled Crossover Study to Evaluate the Effects of Esaxerenone on QTc Interval in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 709, doi. 10.1002/cpdd.794
- By:
- Publication type:
- Article
4
Modeling and Simulation of the Pharmacokinetics and Target Engagement of an Antagonist Monoclonal Antibody to Interferon‐γ–Induced Protein 10, BMS‐986184, in Healthy Participants to Guide Therapeutic Dosing.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 689, doi. 10.1002/cpdd.784
- By:
- Publication type:
- Article
5
Base and Covariate Population Pharmacokinetic Analyses of Dupilumab Using Phase 3 Data.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 756, doi. 10.1002/cpdd.780
- By:
- Publication type:
- Article
6
Evaluation of the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Pyrimethamine in Healthy Male Subjects of Japanese and European Ancestry.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 768, doi. 10.1002/cpdd.771
- By:
- Publication type:
- Article
7
Evaluation of Pharmacokinetics and Dose Proportionality of Diazepam After Intranasal Administration of NRL‐1 to Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 719, doi. 10.1002/cpdd.767
- By:
- Publication type:
- Article
8
Evaluation of Clinical Cardiac Safety of Itacitinib, a JAK1 Inhibitor, in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 677, doi. 10.1002/cpdd.758
- By:
- Publication type:
- Article
9
Pharmacokinetics, Bioequivalence, and Safety Studies of Prucalopride in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 671, doi. 10.1002/cpdd.754
- By:
- Publication type:
- Article
10
Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 664, doi. 10.1002/cpdd.753
- By:
- Publication type:
- Article
11
A Mass Balance Study of <sup>14</sup>C‐Labeled JTZ‐951 (Enarodustat), a Novel Orally Available Erythropoiesis‐Stimulating Agent, in Patients With End‐Stage Renal Disease on Hemodialysis.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 728, doi. 10.1002/cpdd.752
- By:
- Publication type:
- Article
12
Pharmacokinetics and Safety of a Single Oral Dose of Peficitinib (ASP015K) in Japanese Subjects With Normal and Impaired Hepatic Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 699, doi. 10.1002/cpdd.751
- By:
- Publication type:
- Article
13
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2020, v. 9, n. 6, p. 659, doi. 10.1002/cpdd.680
- Publication type:
- Article